Evidence map›Paper›PMID 26935752›Full record

ArticleBMC public health2016

Bio-behavioural HIV and STI surveillance among men who have sex with men in Europe: the Sialon II protocols.

Lorenzo Gios, Massimo Mirandola, Igor Toskin, Ulrich Marcus, Sandra Dudareva-Vizule, Nigel Sherriff, Michele Breveglieri, Martina Furegato, Cinta Folch, Laia Ferrer and 14 more

Abstract read
In one paragraph

Article in BMC public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sexual autonomy and self-reported sexually transmitted infections among women in sexual unions.Archives of public health = Archives belges de sante publique · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Quantifying unmet prevention needs among MSM in Europe through a multi-site bio-behavioural survey.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lorenzo GiosVeneto Region - Department of Health, CReMPE - Regional Coordination Centre for European Project Management, the Verona University Hospital, Verona, Italy. gios.lorenzo@gmail.com.
Massimo MirandolaVeneto Region - Department of Health, CReMPE - Regional Coordination Centre for European Project Management, the Verona University Hospital, Verona, Italy. massimo.mirandola@regione.veneto.it.
Igor ToskinDepartment of Reproductive Health & Research, World Health Organization, Geneva, Switzerland. toskini@who.int.
Ulrich MarcusDepartment for Infectious Diseases Epidemiology, Robert Koch-Institute, Berlin, Germany. MarcusU@rki.de.
Sandra Dudareva-VizuleDepartment for Infectious Diseases Epidemiology, Robert Koch-Institute, Berlin, Germany. Dudareva-VizuleS@rki.de.
Nigel SherriffCentre for Health Research, University of Brighton, Brighton, UK. n.s.sherriff@brighton.ac.uk.
Michele BreveglieriVeneto Region - Department of Health, CReMPE - Regional Coordination Centre for European Project Management, the Verona University Hospital, Verona, Italy. michele.breveglieri@ospedaleuniverona.it.
Martina FuregatoVeneto Region - Department of Health, CReMPE - Regional Coordination Centre for European Project Management, the Verona University Hospital, Verona, Italy. martina.furegato@ospedaleuniverona.it.
Cinta FolchInstitut Catala d'Oncologia (ICO), Centre for Epidemiological Studies on HIV/STI in Catalonia (CEEISCAT), Agencia de Salut Publica de Catalunya (ASPC), Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. cfolch@iconcologia.net.
Laia FerrerInstitut Catala d'Oncologia (ICO), Centre for Epidemiological Studies on HIV/STI in Catalonia (CEEISCAT), Agencia de Salut Publica de Catalunya (ASPC), Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. lfserret@iconcologia.net.
Alexandra MontoliuInstitut Catala d'Oncologia (ICO), Centre for Epidemiological Studies on HIV/STI in Catalonia (CEEISCAT), Agencia de Salut Publica de Catalunya (ASPC), Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. amontoliu@iconcologia.net.
Christiana NöstlingerDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium. cnoestlinger@itg.be.
Wim Vanden BergheDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium. Wvandenberghe@itg.be.
Sharon Kühlmann-BerenzonDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden. sharon.kuhlmann-b@folkhalsomyndigheten.se.
Inga VelickoDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden. inga.velicko@folkhalsomyndigheten.se.
Sónia DiasInstitute of Hygiene and Tropical Medicine & GHTM, Universidade Nova de Lisboa, Lisbon, Portugal. smfdias@yahoo.com.
Barbara SuligoiCentro Operativo AIDS, Dipartimento di Malattie Infettive, Parassitarie ed Immunomediate, Istituto Superiore di Sanità, Rome, Italy. barbara.suligoi@iss.it.
Vincenza RegineCentro Operativo AIDS, Dipartimento di Malattie Infettive, Parassitarie ed Immunomediate, Istituto Superiore di Sanità, Rome, Italy. vincenza.regine@iss.it.
Danica StanekovaNRC for HIV/AIDS, Slovak Medical University, Bratislava, Slovak Republic. danica.stanekova@szu.sk.
Magdalena RosińskaDepartment of Epidemiology, National Institute of Public Health, National Institute of Hygiene, Warsaw, Poland. mrosinska@pzh.gov.pl.
Saulius CaplinskasCentre for Communicable Diseases and AIDS, Vilnius, Lithuania. saulius.caplinskas@ulac.lt.
Irena KlavsNational Institute of Public Health, Ljubljana, Slovenia. irena.klavs@nijz.si.
Ivailo AlexievNational Reference Laboratory of HIV, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria. ivoalexiev@yahoo.com.
Alexandru RafilaNational Institute of Infectious Diseases Prof. Dr. Matei Bals, Bucharest, Romania.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundGlobally, the HIV epidemic continues to represent a pressing public health issue in Europe and elsewhere. There is an emerging and progressively urgent need to harmonise HIV and STI behavioural surveillance among MSM across European countries through the adoption of common indicators, as well as the development of trend analysis in order to monitor the HIV-STI epidemic over time. The Sialon II project protocols have been elaborated for the purpose of implementing a large-scale bio-behavioural survey among MSM in Europe in line with a Second Generation Surveillance System (SGSS) approach. METHODS/

designSialon II is a multi-centre biological and behavioural cross-sectional survey carried out across 13 European countries (Belgium, Bulgaria, Germany, Italy, Lithuania, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the UK) in community settings. A total of 4,966 MSM were enrolled in the study (3,661 participants in the TLS survey, 1,305 participants in the RDS survey). Three distinct components are foreseen in the study protocols: first, a preliminary formative research in each participating country. Second, collection of primary data using two sampling methods designed specifically for 'hard-to-reach' populations, namely Time Location Sampling (TLS) and Respondent Driven Sampling (RDS). Third, implementation of a targeted HIV/STI prevention campaign in the broader context of the data collection. DISCUSSION: Through the implementation of combined and targeted prevention complemented by meaningful surveillance among MSM, Sialon II represents a unique opportunity to pilot a bio-behavioural survey in community settings in line with the SGSS approach in a large number of EU countries. Data generated through this survey will not only provide a valuable snapshot of the HIV epidemic in MSM but will also offer an important trend analysis of the epidemiology of HIV and other STIs over time across Europe. Therefore, the Sialon II protocol and findings are likely to contribute significantly to increasing the comparability of data in EU countries through the use of common indicators and in contributing to the development of effective public health strategies and policies in areas of high need.

Indexed as

EpidemicsAdultCross-Sectional StudiesEuropeHIV InfectionsHomosexuality, MaleHumansMalePopulation SurveillanceSexually Transmitted DiseasesSurveys and QuestionnairesYoung Adult

Identifiers

PMID26935752
PMCPMC4776381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.